NCT07342660

Brief Summary

Background: Cerebral Palsy (CP) is characterized by altered excitability in bilateral sensorimotor cortical areas. Previous research using unilateral anodal transcranial direct current stimulation (tDCS) has yielded inconsistent results, highlighting a need for alternative stimulation approaches. Objective: This study evaluated the feasibility, safety, and preliminary efficacy of combining bilateral anodal transcranial direct current stimulation (tDCS) over the sensorimotor cortices with treadmill training in children with CP. Methods: A within-subjects case series was conducted with five children with CP. Participants received ten sessions of treadmill training (at 50% of their maximum over-ground speed) concurrently with bilateral anodal tDCS. Outcomes, assessed pre- and post-intervention, included postural alignment (medio-lateral and anterior-posterior), ankle dorsiflexion range of motion, gait variability, walking tolerance (6-minute walk test), motor function (GMFM-66), and hip/knee range of motion. Statistical analysis was performed using paired t-tests and effect sizes (Hedges' g). Anticipated Impact: This study will pioneer a novel bilateral tDCS montage for CP rehabilitation. The findings are expected to provide critical insights into the synergistic relationship between neuromodulation and physical training, ultimately informing more effective, evidence-based interventions to enhance motor function and participation in this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

4.8 years

First QC Date

November 22, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

Cerebral palsytranscranial direct current stimulationtreadmillgait functionbalance

Outcome Measures

Primary Outcomes (5)

  • Gait speed

    Gait speed (meters/second)

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

  • Gait variability

    Gait variability (dimensionless autocorrelation coefficient)

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

  • Walking endurance

    Walking endurance assessed using the 6-Minute Walk Test (distance in meters walked within 6 minutes intervals)

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

  • Developmental Motor function

    Gross motor function measure - Item set scale (Total Score, Higher score good motor function development, lower score poor motor function development)

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

  • Postural Alignment

    Postural alignment (medio-lateral displacement in cm) Postural alignment (anterior-posterior displacement in cm)

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

Secondary Outcomes (2)

  • Spasticity

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

  • Joint Range of Motion

    Baseline (within 7 days prior to the first intervention session) Immediately post-intervention (within 7 days following completion of the 10-session intervention period; up to 4 weeks from baseline)

Study Arms (1)

tDCS & Treadmill

EXPERIMENTAL

The therapeutic protocol commenced with two treadmill familiarization sessions. This was followed by ten combined treatment sessions.

Other: transcranial direct current stimulation

Interventions

The therapeutic protocol commenced with two treadmill familiarization sessions. This was followed by ten combined treatment sessions, each consisting of a 12-minute interval: a 1-minute warm-up, a 10-minute simultaneous treadmill training and tDCS therapy period, and a 1-minute cool-down. Treadmill speed was initiated at 50% of the child's maximum ground speed from the 6-Minute Walk Test (6MWT) and was progressively increased based on individual tolerance.

Also known as: treadmill
tDCS & Treadmill

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gross Motor Function Classification System (GMFCS) level of I-III
  • ability to walk independently for at least 10 meters
  • IQ greater than 70

You may not qualify if:

  • history of orthopedic surgery
  • history of neurolytic blocks,
  • history of Botox injections in the past six months
  • Presence of concurrent orthopedic impairments
  • Presence of epilepsy
  • Presence of intracranial metal implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sharjah

Sharjah city, Emirate of Sharjah, 27272, United Arab Emirates

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Transcranial Direct Current StimulationExercise Test

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Hikmat Hadoush

    University of Sharjah

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. / Associate professor

Study Record Dates

First Submitted

November 22, 2025

First Posted

January 15, 2026

Study Start

July 1, 2020

Primary Completion

May 1, 2025

Study Completion

July 1, 2025

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) collected during the study will be made available. This will include analyzable datasets underlying the reported outcomes, such as gait parameters, range of motion measures, walking endurance (6-Minute Walk Test), and Gross Motor Function Measure (GMFM-66) scores. No direct identifiers will be shared. Supporting documentation, including the study protocol and statistical analysis plan, may also be made available upon request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months after publication of the primary study results and available for 5 years thereafter.
Access Criteria
De-identified IPD will be available upon reasonable request from qualified researchers for the purpose of academic, educational, or non-commercial research.

Locations